Practical Guide to EU Funding for Research, Development & Innovation

The EU supports research and innovation activities through a range of programmes, including the Seventh Framework Programme for Research (FP7), the Competitiveness and Innovation Programme (CIP) and Structural Funds. Now the European Commission is developing a guide to help researchers select the right programme for their activities and even combine funds from different sources. A draft version of the guide is now ready and the Commission is keen to receive feedback on the document from the research community.

At the heart of the guide is a six-point checklist designed to help researchers identify the most relevant funding source for their needs. Questions cover the eligibility of the organisation or company, the eligibility of the planned activity, the timeframe for the project, the type of financial support needed and the identity of any other partners involved.

With a budget of over €50 billion for the period 2007 to 2013, FP7 is the EU's main instrument for the support of research and development activities. Meanwhile the €3.6 billion CIP initiative aims to boost the competitiveness of European businesses, with a focus on eco-innovation, information and communication technologies (ICTs) and renewable energies and energy efficiency.

Structural Funds are designed to reduce disparities in the level of development among regions and Member States. Although the amount of funding allocated to research and innovation varies from region to region, it is estimated that the total amount allocated to these activities will top the €99 billion mark for the period 2007 to 2013.

The guide explains how funds from these three sources can be combined to best effect, without falling foul of co-financing rules (which require recipients of most EU funds to finance part of their project from non-EU sources). The trick, according to the guide, is to use complementary financing.

"For example, separate but related activities or parts of a project can be funded by the Structural Funds, FP7 or the CIP," the guide reads. "Equally, the different funding sources may support different phases of the development of a technology over time, starting from basic research, to applied research, to demonstration or to pre-competitive market introduction."

A series of examples illustrates how different organisations might draw on different funds for different activities or phases of their projects.

The guide also notes that now is a good time to combine funds from these three sources. They share a common timeframe (2007 to 2013), and thanks to the Lisbon Strategy, research and innovation are now seen as crucial for regional development, a fact which is reflected in the Structural Funds. At the same time, the role of the regions in research is taken into account in both FP7 and CIP.

The Commission is keen to receive comments and suggestions by the end of April on how the guide can be made even more practical and user-friendly. Once finalised, the online version of the guide will be updated regularly and will also include links to the relevant national and regional programmes.

For further information, and a copy of the draft Practical Guide, please visit:
http://cordis.europa.eu/eu-funding-guide/home_en.html

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...